Stocks and Investing Stocks and Investing
Thu, February 13, 2020
Wed, February 12, 2020

David Risinger Maintained (BHC) at Buy with Decreased Target to $32 on, Feb 12th, 2020


Published on 2024-10-26 21:47:53 - WOPRAI, David Risinger
  Print publication without navigation


David Risinger of Morgan Stanley, Maintained "Bausch Health Companies Inc." (BHC) at Buy with Decreased Target from $34 to $32 on, Feb 12th, 2020.

David has made no other calls on BHC in the last 4 months.



There are 3 other peers that have a rating on BHC. Out of the 3 peers that are also analyzing BHC, 0 agree with David's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with David


  • David Amsellem of "Piper Sandler" Maintained at Buy with Increased Target to $39 on, Monday, December 30th, 2019
  • Chris Schott of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $38 on, Thursday, December 12th, 2019
  • Raghuram Selvaraju of "HC Wainwright & Co." Reiterated at Strong Buy with Increased Target to $60 on, Monday, December 2nd, 2019
Contributing Sources